AnaptysBio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AnaptysBio generated cash of -$120,800,000, which is less than the previous year. Cash used in financing activities reached the amount of -$59,297,000 last year. Net change in cash is therefore -$35,343,000.
Cash Flow
| 2014 | 14.60M | -140K | 4.91M |
|---|---|---|---|
| 2015 | -9.66M | -238K | 39.40M |
| 2016 | -9.03M | -50K | 8.62M |
| 2017 | -19.43M | -243.05M | 292.45M |
| 2018 | -48.50M | -142.45M | 223.36M |
| 2019 | -69.51M | 131.43M | -4.49M |
| 2020 | -14.15M | 94.47M | -879K |
| 2021 | -45.92M | 38.83M | 252.29M |
| 2022 | -73.59M | -394.84M | 44.01M |
| 2023 | -120.8M | 144.75M | -59.29M |
ANAB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 71.30M | 495.72M | 250.51M | 171.07M | 113.65M | 81.24M | 51.29M | 51.68M | 22.18M | 2.81M |
Operating activities | ||||||||||
Net income | -163.61M | -128.72M | -57.79M | -19.93M | -97.33M | -61.65M | -30.07M | -4.25M | -5.40M | 3.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.37M | 2.33M | 2.09M | 559K | 514K | 315K | 183K | 233K | 274K | 308K |
Stock-based compensation expense | 33.20M | 27.35M | 15.34M | 11.49M | 12.41M | 0 | 4.37M | 1.16M | 604K | 160K |
| Deferred income tax benefit | 33.20M | 27.35M | 15.34M | 11.49M | 12.41M | 0 | 4.37M | 1.16M | 604K | 160K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -543K | -876K | 0 | 174K | 0 | 1.22M | 1K | 229K | -1.45M |
Inventories | 0 | 0 | 0 | 0 | -174K | 0 | -237.97M | -5.33M | 343K | -489K |
Accounts payable | 10.93M | 9.7M | -4.74M | -8.87M | 14.49M | 7.08M | 2.21M | 1.25M | 1.94M | 482K |
Cash generated by operating activities | -120.8M | -73.59M | -45.92M | -14.15M | -69.51M | -48.50M | -19.43M | -9.03M | -9.66M | 14.60M |
Investing activities | ||||||||||
Purchases Of Investments | -303.91M | -802.50M | -118.66M | -194.92M | -251.81M | -347.53M | -290.90M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -807K | -358K | -1.36M | -569K | -805K | -1.06M | -290K | -50K | -238K | -145K |
Acquisitions Net | 0 | 394.48M | 15K | 194.92M | 251.81M | 347.53M | 290.90M | 0 | 0 | 0 |
Cash generated by investing activities | 144.75M | -394.84M | 38.83M | 94.47M | 131.43M | -142.45M | -243.05M | -50K | -238K | -140K |
Financing activities | ||||||||||
Common Stock Issued | 2.47M | 11.82M | 2.55M | 496K | 3.00M | 227.47M | 292.53M | 31K | 160K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -50M | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 |
Repayments of term debt | -11.72M | 0 | -72K | -1.37M | -7.5M | -6.87M | 0 | 0 | 0 | 0 |
Cash used in financing activities | -59.29M | 44.01M | 252.29M | -879K | -4.49M | 223.36M | 292.45M | 8.62M | 39.40M | 4.91M |
Net Change In Cash | -35.34M | -424.42M | 245.21M | 79.43M | 57.42M | 32.40M | 29.95M | -452K | 29.49M | 19.37M |
Cash at end of period | 35.96M | 71.30M | 495.72M | 250.51M | 171.07M | 113.65M | 81.24M | 51.23M | 51.68M | 22.18M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |